Consales Alessandra, Agostoni Carlo, Cazzola Roberta, Ottria Roberta, Giannì Maria Lorella
Department of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, University of Milan, Milan, Italy.
Department of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, University of Milan, Milan, Italy; Pediatric Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Adv Nutr. 2024 Dec;15(12):100295. doi: 10.1016/j.advnut.2024.100295. Epub 2024 Nov 8.
Zinc (Zn) is a trace element involved in numerous physiological processes, including enzyme function, gene transcription, and cell signaling. Its importance is especially pronounced in preterm infants, who are at high risk of Zn deficiency due to disrupted transplacental transfer, high nutrient demands, and medical complications. The inherent risk of Zn deficiency in this population is further increased by poor Zn dietary intake. Human milk from preterm mothers contains low concentrations of Zn, although it is highly bioavailable. Additionally, the Zn content steadily declines from colostrum (first few days postpartum) to mature milk (>10-14 d postpartum). Formula milk contains higher Zn concentrations to compensate for nutrient losses during production and storage, and lower bioavailability compared with human milk, which is further decreased in case of high phytate content, such as in soy milk-based formulas. Zn supplements may prove useful in meeting the preterm infant's needs, although caution is warranted regarding potential interactions with other nutrients within multinutrient supplements. Early detection of Zn deficiency is challenging due to the lack of reliable Zn status biomarkers, necessitating a high index of suspicion. Clinical signs of Zn deficiency can range from mild, nonspecific symptoms to severe, multisystem involvement. Chronic deficiency may lead to failure to thrive. Zn supplementation can support growth and mitigate comorbidities in preterm infants, although variability across studies complicates efforts to establish optimal dosing, and define safety and long-term effects. Although rare, Zn toxicity in preterm infants should not be overlooked, especially in infants on long-term parenteral nutrition. This narrative review aimed to consolidate existing knowledge and identify research gaps, highlighting the critical role of Zn in supporting preterm infants' health. Further research is needed to establish evidence-based practices to improve health outcomes in this vulnerable population.
锌(Zn)是一种参与众多生理过程的微量元素,包括酶功能、基因转录和细胞信号传导。其重要性在早产儿中尤为明显,由于经胎盘转运中断、营养需求高和医疗并发症,早产儿面临锌缺乏的高风险。该人群锌缺乏的固有风险因锌的膳食摄入量低而进一步增加。早产母亲的母乳中锌浓度较低,尽管其生物利用率很高。此外,锌含量从初乳(产后头几天)到成熟乳(产后>10 - 14天)稳步下降。配方奶含有较高的锌浓度以补偿生产和储存过程中的营养损失,但其生物利用率低于母乳,在植酸含量高的情况下(如大豆基配方奶),生物利用率会进一步降低。锌补充剂可能有助于满足早产儿的需求,尽管对于多种营养素补充剂中锌与其他营养素之间的潜在相互作用需要谨慎。由于缺乏可靠的锌状态生物标志物,早期检测锌缺乏具有挑战性,因此需要高度怀疑。锌缺乏的临床症状范围从轻微的非特异性症状到严重的多系统受累。慢性缺乏可能导致发育不良。锌补充剂可以支持早产儿的生长并减轻合并症,尽管各研究之间的差异使确定最佳剂量以及定义安全性和长期影响的努力变得复杂。尽管罕见,但早产儿的锌中毒不应被忽视,尤其是长期接受肠外营养的婴儿。本叙述性综述旨在整合现有知识并确定研究差距,强调锌在支持早产儿健康方面的关键作用。需要进一步研究以建立基于证据的实践方法,以改善这一脆弱人群的健康结局。